IONS vs. QBTS

In the year-to-date period, IONS achieves a -4.15% return, which is significantly lower than QBTS's 94.40% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Ionis Pharmaceuticals, Inc. (IONS) and DPCM Capital Inc (QBTS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current IONS Sharpe Ratio is -0.20, which is lower than the QBTS Sharpe Ratio of 6.49. The chart below compares the historical Sharpe Ratios of IONS and QBTS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither IONS nor QBTS has paid dividends to shareholders.

The maximum IONS drawdown since its inception was -91.72%, smaller than the maximum QBTS drawdown of -96.67%. Use the drawdown chart below to compare losses from any high point for IONS and QBTS.

The current volatility for Ionis Pharmaceuticals, Inc. (IONS) is 11.73%, while DPCM Capital Inc (QBTS) has a volatility of 55.99%. This indicates that IONS experiences smaller price fluctuations and is considered to be less risky than QBTS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Ionis Pharmaceuticals, Inc. and DPCM Capital Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.